COVID-19 Records

Email

Gates Package, pp.189-190 · gates:email:00120

Page text: p.189, p.190 · original PDF

Date
2018-05-25 17:02
Type
email · email
cc
Lawrence A. Tabak
sender
Francis S. Collins
to
Roger Glass, Anthony S. Fauci
Topics
Gates Foundation involvementTherapeutics and treatmentsVaccines
nih.gov>; Wolinetz, Carrie (NIH/OD) [E] @nih.gov>; Lauer, Michael (NIH/OD) [E] <_EEOnih.gov> >> Subject: Re: Need info on BMGF -- Urgent >> >> Just spoke with Larry, he has the full scoop > >> Sent from my iPhone >> >>> On May 25, 2018, at 4:55 PM, Collins, Francis (NIH/OD) [E] <{f@od.nih.gov> wrote: >>> >>> For reasons I can't currently explain, I need answers to the following: >>> 1) are we giving any grants to BMGF (I assume no) >>> 2) what are our current collaborative projects with BMGF? For each one , what is the rough NIH annual spend, and what is it from BMGF? >>> >>> Hoping this won't be too hard to dig out. Ideally I need a response (at least a rough version) by Saturday 4 pm. >>> >>> Questions? Call [EE Getting on a plane in 10 minutes >>> >>> FC >>> >>> Sent from my iPhone G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# Agreement Type Effective Date Expiration Da External Parties *Lead Pl 2009-0021 CTA - Clinical Trial Agreement 7/1/2009) Baxter Healthcare Corporation Steven Holland 2009-0207 CRADA 7/13/2009 Chimerix, Inc. Jeffrey Cohen 2009-0229 CRADA 8/22/2009] 8/22/2023|Lexicon Pharmaceuticals, Inc. Thomas Leto Ception Therapeutics (acq Cephalon/Teva 2009-0547 CTA - Clinical Trial Agreement 10/26/2009} Pharmaceutical Industries) [US] Amy Klion 2009-0573 CTA - Clinical Trial Agreement 10/19/2009 Genentech, Inc. Melody Carter Massachusetts General Hospital (MGH; General 2009-0577 Letter of Intent/MOU 8/17/2009 Hospital Corp.) Massachusetts General Hospital (MGH; General 2009-0577 Letter of Intent/MOU 8/17/2009} Hospital Corp.) 2009-0624 Research Collaboration Agreement 6/19/2012] 8/18/2016]University of Texas Health Center at Tyler Adrian Zelazny 2009-0763 CTA - Clinical Trial Agreement 11/30/2009! NexBio, Inc. Richard Davey Stanford University (Leland Stanford Junior 2009-0910 Letter of Intent/MOU 12/18/2009 University), University of Rochester Kanta Subbarao Center for Infectious Disease Research (CID) 2009-0929 Gift 3/9/2010} (Formerly Seattle Biomed) (Merged w Patrick Duffy Massachusetts General Hospital (MGH; General 2009-0953 Gift 2/29/2016] 7/31/2016]Hospital Corp.) Clifton Barry Massachusetts General Hospital (MGH; General 2009-0953 Gift 2/29/2016] 7/31/2016}Hospital Corp.) Clifton Barry Australian Nuclear Science and Technology 2010-0133 Research Collaboration Agreement 6/15/2010 Organisation [AU] Australian Nuclear Science and Technology 2010-0133 Research Collaboration Agreement 6/15/2010) Organisation [AU] 2010-0151 Research Collaboration Agreement 6/12/2015] 6/21/2018] University of Wisconsin-Madison [US] Heinrich Feldmann 2010-0278 CRADA 9/30/2010] 9/30/2018|Hawaii Biotech, Inc. Stephen Leppla 2010-0291 Gift 4/28/2010) Bill & Melinda Gates Foundation (BMGF) 2010-0291 Gift

Extracted statements

Rule-extracted, not adjudicated. The grade says what may be done with each one; read the document above before relying on any of them.

StatementGradeAttributionStance
nih.gov>; Wolinetz, Carrie (NIH/OD) [E] @nih.gov>; Lauer, Michael (NIH/OD) [E] <_EEOnih.gov> >> Subject: Re: Need info on BMGF -- Urgent >> >> Just spoke with Larry, he has the full scoop > >> Sent from my iPhone >> >>> On May 25, 2018, at 4:55 PM, Collins, Francis (NIH/OD) [E] <{f@od.nih.gov> wrote: >>> >>> For reasons I can't currently explain, I need answers to the following: >>> 1) are we giving any grants to BMGF (I assume no) >>> 2) what are our current collaborative projects with BMGF? quoted / not their view quoted_external message body appears to be pasted content questions
For each one , what is the rough NIH annual spend, and what is it from BMGF? >>> >>> Hoping this won't be too hard to dig out. quoted / not their view quoted_external message body appears to be pasted content questions